Nyxoah to Host Investor Day on July 8 in New York Featuring Genio
Medical technology company Nyxoah will host an Investor Day on Wednesday, July 8 in New York, focusing on its growth strategy. The leadership and board will detail the commercial execution of its Genio system in the American market, as well as key steps towards profitability.
A Half-Day Event Focused on Three Strategic Pillars
Nyxoah will hold its Investor and Analyst Day on Wednesday, July 8, 2026, from 10:00 AM to 12:30 PM (New York time) at the Bank of America offices in Manhattan. The event will be broadcast live for remote participants, with a recording available afterward. Investors and analysts joining via webcast will be able to ask questions in real time. The agenda will cover three areas: the commercial dynamics of Genio in the U.S., including key performance indicators for the second quarter; the reimbursement outlook in the American landscape, presented in partnership with JD Lymon Group, an independent firm specializing in market access and reimbursement; and the path to profitability, outlining the company's framework for disciplined growth and capital efficiency.
Participation Including Leadership, Board, and External Experts
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Robert Taub, chairman of the board, and Olivier Taelman, CEO, will participate along with the executive team. The event will also bring together two sleep specialists (Andrew T. Huang and Vikas Jain) as well as JD Lymon Group to provide a clinical and market perspective on obstructive sleep apnea and its reimbursement ecosystem in the U.S. Participants can register via Nyxoah's investor site or by contacting IR@nyxoah.com to access the webcast.
Related
SectorDispositifs médicaux et optique›Dispositifs médicaux
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 14 millions d'euros
Quarterly revenue: 14 millions d'euros
Revenue growth: 484,4 %
Net income: -48,9 millions d'euros
Guidance from the release
nous sommes confiants dans le fait que l'environnement de remboursement actuel soutient l'accélération de notre croissance du chiffre d'affaires aux États-Unis
Risks mentioned
Baisse de la marge brute à 59 % au S1 2026 due à des problèmes de rendement de production au T1 et à un mix de revenus américain plus important
Augmentation des charges de vente, générales et administratives liée au déploiement commercial aux États-Unis
Perte opérationnelle en hausse à 41,1 M€ au S1 2026 contre 40,5 M€ au S1 2025
Opportunities identified
Financement de 110 millions de dollars sécurisé au T2 2026 pour financer la croissance commerciale
Taux d'approbation de 100 % sur les demandes d'autorisation préalable pour les patients commerciaux et WISeR
Code Medicare C-code 8011 dédié à Genio, clarifiant le paysage de remboursement
Outlook / guidance
Expected revenue: 38 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.